Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Effect van endovasculaire trombectomie in subgroepen: DEFUSE 3
mrt 2019 | Neuro-vasculair